BMGL · Basel Medical Group Ltd
United States · RS rating 53 · As of 2026-10-14
| Price | 3.85 USD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 53 / 7 / 11 / 97 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 30 / 48 / 23 |
| Industry group (rank) | Medical-Hospitals (22) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +53.9% |
| Market cap (USD) | $11.6M |